Loading clinical trials...
Loading clinical trials...
This is a prospective, multicenter, two-cohort, open-label, single-arm feasibility study of a trimodal (nutritional, psychological, and personalized Adapted Physical Activity (APA)-individualized inte...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
NCT06713993 · Esophageal Cancer (EsC)
NCT02600949 · Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, and more
NCT06921928 · Gastric Cancer, Gastroesophageal Junction Cancer, and more
NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more
NCT06423326 · Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, and more
Centre Hospitalier Universitaire Dijon Bourgogne
Dijon
Institut Daniel Hollard - Groupe Hospitalier Mutualiste de Grenoble
Grenoble
Centre Hospitalier Universitaire de Lille
Lille
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions